An epilepsy drug could lead to a new treatment that protects nerve damage in MS patients, according to research published in the Lancet Neurology.
Jan 25, 2016
0
196
Withdrawing a commonly-prescribed Alzheimer's disease drug from people in the advanced stages of the disease doubles their risk of being placed in a nursing home within a year, according to UCL research published today in ...
Oct 27, 2015
0
108
A third of Alzheimer's disease cases worldwide can be attributed to risk facts that can be potentially modified, such as lack of education and physical inactivity, according to NIHR-funded research published in The Lancet ...
Jul 14, 2014
0
0
In a Review published in The Lancet Neurology, two of the world's leading experts on the link between environment and children's health are sounding the alarm on the dangers of industrial chemicals.
Feb 14, 2014
1
0
For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade ...
Sep 23, 2013
0
0
Uncontrolled high blood pressure damages the brain's structure and function as early as young middle-age, and even the brains of middle-aged people who clinically would not be considered to have hypertension have evidence ...
Oct 31, 2012
0
0
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, ...
Oct 17, 2012
1
0
A team of Canadian scientists and clinicians, led by Dr. Michael Hill of the Calgary Stroke Program at Foothills Medical Centre and University of Calgary's Hotchkiss Brain Institute (HBI), have demonstrated that a neuroprotectant ...
Oct 9, 2012
1
0
Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet Neurology.
Apr 13, 2024
0
4
Parkinson's disease is a neurodegenerative movement disorder that progresses relentlessly. It gradually impairs a person's ability to function until they ultimately become immobile and often develop dementia. In the U.S. ...
Apr 11, 2024
0
1
